» Articles » PMID: 12163417

Conditional Loss of PTEN Leads to Precocious Development and Neoplasia in the Mammary Gland

Overview
Journal Development
Specialty Biology
Date 2002 Aug 7
PMID 12163417
Citations 123
Authors
Affiliations
Soon will be listed here.
Abstract

PTEN tumor suppressor is frequently mutated in human cancers, including breast cancers. Female patients with inherited PTEN mutations suffer from virginal hypertrophy of the breast with high risk of malignant transformation. However, the exact mechanisms of PTEN in controlling mammary gland development and tumorigenesis are unclear. In this study, we generated mice with a mammary-specific deletion of the Pten gene. Mutant mammary tissue displayed precocious lobulo-alveolar development, excessive ductal branching, delayed involution and severely reduced apoptosis. Pten null mammary epithelial cells were disregulated and hyperproliferative. Mutant females developed mammary tumors early in life. Similar phenotypes were observed in Pten-null mammary epithelia that had been transplanted into wild-type stroma, suggesting that PTEN plays an essential and cell-autonomous role in controlling the proliferation, differentiation and apoptosis of mammary epithelial cells.

Citing Articles

Injectable Biomimetic Hydrogel Constructs for Cell-Based Menopausal Hormone Therapy with Reduced Breast Cancer Potential.

Yang C, Yang H, Kim H, Chung N, Shin J, Min H Biomater Res. 2024; 28:0054.

PMID: 39135549 PMC: 11310713. DOI: 10.34133/bmr.0054.


Elevated expression of wildtype RhoC promotes ErbB2- and Pik3ca-induced mammary tumor formation.

Raghuram N, Temel E, Kawamata T, Kozma K, Loch A, Wang W Breast Cancer Res. 2024; 26(1):86.

PMID: 38807216 PMC: 11134842. DOI: 10.1186/s13058-024-01842-5.


Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancer.

Treekitkarnmongkol W, Shah V, Kai K, Katayama H, Wong J, Ladha F Br J Cancer. 2024; 131(1):171-183.

PMID: 38760444 PMC: 11231151. DOI: 10.1038/s41416-024-02697-5.


Active Gα Mutants Accelerate Breast Tumor Metastasis via the c-Src Pathway.

Lyu C, Bhimani A, Draus W, Weigel R, Chen S Mol Cell Biol. 2023; 43(12):650-663.

PMID: 38099640 PMC: 10761066. DOI: 10.1080/10985549.2023.2285833.


Recent advances in targeted strategies for triple-negative breast cancer.

Zhu S, Wu Y, Song B, Yi M, Yan Y, Mei Q J Hematol Oncol. 2023; 16(1):100.

PMID: 37641116 PMC: 10464091. DOI: 10.1186/s13045-023-01497-3.